Announcements Trials
Browse Landscape

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Conditions

Turcot syndrome 1Lymphatic Metastasis 1

Interventions

pembrolizumab 4Nivolumab 2toripalimab 1relatlimab 1fludarabine phosphate 1fludarabine 1denileukin diftitox 1Specimen Handling 1Magnetic Resonance Spectroscopy 1Irinotecan 1Ipilimumab 1E7777 fusion protein 1Diffusion Tensor Imaging 1DNA Mismatch Repair 1Cyclophosphamide 1Celecoxib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Turcot syndrome × DNA Mismatch Repair × 90 days × Clear all
NCT07625735 2026-06-04

MMR Status Modulates the Predictive Value of Lymphatic Invasion for Lymph Node Metastasis in Gastric Cancer

Shanghai Zhongshan Hospital

Not yet recruiting
3,000 enrolled

Turcot syndrome, Lymphatic Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡